Opportunities at Karolinska Institutet

The Karolinska Institutet(KI) is a strategic partner of the University of Edinburgh (further details can be found here) and a fellow member of Eurolife, which promotes exchange and joint training.  The KI has strong collaborative links and joint grants with both Scottish partners in the Precision Medicine programme in target disease areas. KI benefits from major health data science assets and biorepositories, now being co-ordinated in a drive to consolidate Stockholm as one of the top environments for Precision Medicine in the world. You can hear more about the developments in Precision Medicine infrastructure at the KI and in Sweden in this talk to a recent joint Edinburgh/Glasgow/Karolinska seminar given by Prof Richard Rosenquist

Precision Medicine students can benefit from partnership with the KI in a variety of ways. Some projects feature KI co-supervisors, often with dedicated periods of research spent at the KI. Around 20% of projects in the last 2 admissions cycles have featured a KI co-supervisor, and we aim to increase this to 30% in the new programme. Many DTP students have also attended the outstanding training courses run by the KI. Support for attending these can be sought from the flexible funding calls run annually within the programme. Some of the programme students reflected on their KI co-supervised projects and/or training courses at the recent joint symposium:

• Quantitative proteomic analysis of dysregulated adhesion protein localisation in patient-derived cancer cells - Athanasia Yiapanas (Year 3)

• Identifying therapeutic targets that could transform Rheumatoid Arthritis from disease remission into cure - Jack Frew (Year 2)

• Taming the Hippo in mesothelioma through proteogenomics - Krishna Purohit (Year 2; slides only)